Analysis of Safety and Tolerability Data in Pediatric Patients with Primary Immunodeficiency Diseases from Two Phase 2/3 Studies of Human Immune Globulin Subcutaneous, 20%

Kenneth Paris; Elie Haddad; Iftikhar Hussain; Nicholas Brodszki; Amy Liebl Darter; Werner Engl; Barbara McCoy; Leman Yel

doi:10.1016/j.jaci.2016.12.703

Analysis of Safety and Tolerability Data in Pediatric Patients with Primary Immunodeficiency Diseases from Two Phase 2/3 Studies of Human Immune Globulin Subcutaneous, 20%

Kenneth Paris, Elie Haddad, Iftikhar Hussain, Nicholas Brodszki, Amy Liebl Darter, Werner Engl, Barbara McCoy, Leman Yel

Skåne University Hospital

Research output: Contribution to journal › Published meeting abstract › peer-review

Original language	English
Article number	685
Pages (from-to)	AB217
Journal	Journal of Allergy and Clinical Immunology
Volume	139
Issue number	2, Supplement
DOIs	https://doi.org/10.1016/j.jaci.2016.12.703
Publication status	Published - 2017
Externally published	Yes
Event	2017th AAAAI Annual Meeting - Atlanta, United States Duration: 2017 Mar 3 → 2017 Mar 6

Bibliographical note

Programs and Abstracts of Papers to be Presented During Scientific Sessions: 2017 AAAAI Annual Meeting.

Subject classification (UKÄ)

Immunology in the Medical Area (including Cell and Immunotherapy)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jaci.2016.12.703

https://www.sciencedirect.com/science/article/pii/S0091674916322217

Cite this

Paris, K., Haddad, E., Hussain, I., Brodszki, N., Darter, A. L., Engl, W., McCoy, B., & Yel, L. (2017). Analysis of Safety and Tolerability Data in Pediatric Patients with Primary Immunodeficiency Diseases from Two Phase 2/3 Studies of Human Immune Globulin Subcutaneous, 20%. Journal of Allergy and Clinical Immunology, 139(2, Supplement), AB217. Article 685. https://doi.org/10.1016/j.jaci.2016.12.703

@article{4888ff4542d64a018b9f2f3088dd30af,

title = "Analysis of Safety and Tolerability Data in Pediatric Patients with Primary Immunodeficiency Diseases from Two Phase 2/3 Studies of Human Immune Globulin Subcutaneous, 20%",

author = "Kenneth Paris and Elie Haddad and Iftikhar Hussain and Nicholas Brodszki and Darter, {Amy Liebl} and Werner Engl and Barbara McCoy and Leman Yel",

note = "Programs and Abstracts of Papers to be Presented During Scientific Sessions: 2017 AAAAI Annual Meeting.; 2017th AAAAI Annual Meeting ; Conference date: 03-03-2017 Through 06-03-2017",

year = "2017",

doi = "10.1016/j.jaci.2016.12.703",

language = "English",

volume = "139",

pages = "AB217",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier",

number = "2, Supplement",

}

Paris, K, Haddad, E, Hussain, I, Brodszki, N, Darter, AL, Engl, W, McCoy, B & Yel, L 2017, 'Analysis of Safety and Tolerability Data in Pediatric Patients with Primary Immunodeficiency Diseases from Two Phase 2/3 Studies of Human Immune Globulin Subcutaneous, 20%', Journal of Allergy and Clinical Immunology, vol. 139, no. 2, Supplement, 685, pp. AB217. https://doi.org/10.1016/j.jaci.2016.12.703

Analysis of Safety and Tolerability Data in Pediatric Patients with Primary Immunodeficiency Diseases from Two Phase 2/3 Studies of Human Immune Globulin Subcutaneous, 20%. / Paris, Kenneth; Haddad, Elie; Hussain, Iftikhar et al.
In: Journal of Allergy and Clinical Immunology, Vol. 139, No. 2, Supplement, 685, 2017, p. AB217.

Research output: Contribution to journal › Published meeting abstract › peer-review

TY - JOUR

T1 - Analysis of Safety and Tolerability Data in Pediatric Patients with Primary Immunodeficiency Diseases from Two Phase 2/3 Studies of Human Immune Globulin Subcutaneous, 20%

AU - Paris, Kenneth

AU - Haddad, Elie

AU - Hussain, Iftikhar

AU - Brodszki, Nicholas

AU - Darter, Amy Liebl

AU - Engl, Werner

AU - McCoy, Barbara

AU - Yel, Leman

N1 - Programs and Abstracts of Papers to be Presented During Scientific Sessions: 2017 AAAAI Annual Meeting.

PY - 2017

Y1 - 2017

U2 - 10.1016/j.jaci.2016.12.703

DO - 10.1016/j.jaci.2016.12.703

M3 - Published meeting abstract

SN - 0091-6749

VL - 139

SP - AB217

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 2, Supplement

M1 - 685

T2 - 2017th AAAAI Annual Meeting

Y2 - 3 March 2017 through 6 March 2017

ER -